Skip to main content
. 2019 Jun 26;11(7):297. doi: 10.3390/pharmaceutics11070297

Figure 5.

Figure 5

Drug release profiles of the BSA nanoparticles (C/BSA, RosA/BSA, and UrsA/BSA). Pictures of vials show the drug/BSA formulations with (A) curcumin, (B) RosA, or (C) UrsA. Raw drug powders in PBS (pH 7.4) are shown in the bottom images; the arrows indicate the precipitated drug particles at the bottom of the vial or floating in the buffer.